Can prothrombotic gene variants and Apoa1 rs5069 polymorphism be the predictors of early myocardial infarctions?
Turkish Journal of Medical Sciences · 23.08.2024 · 54 (4) · 682-687
DOI: 10.55730/1300-0144.5837 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 23.08.2024. Verfasst von Hüseyin Balcioğlu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir, Turkiye. Hauptthemen laut MEDLINE: Myocardial Infarction, Apolipoprotein A-I. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: We aimed to determine the genetic risk factors in the patients (45 years and below) who had early myocardial infarction history in comparison with the people who had no MI over 60 years of age.Material and method: In this study, we chose different age groups to distinguish genetic differences more clearly. Accordingly, we compared those who had MI at an early age with those who were older and did not experience any cardiovascular events. While 99 volunteers under the age of 45 with a history of MI were included as the patient group, 99 volunteers aged 60 and over without MI history were included as the control group. MTHFR (C677T, A1298C), Factor V Leiden (G1691A), Prothrombin (G20210A), PAI (4G/5G) and Factor XIII (V34L), APOA1 (rs670, rs1799837, rs5069) and APOB were studied with blood samples taken from patients.
Results
In the logistic regression analysis of thrombophilia markers and gene polymorphisms in the patient and control groups, no statistically significant increase was observed in markers other than APOA1 rs5069 gene polymorphism. APOA1 rs5069 gene polymorphism was found to be higher than those without APOA1 rs5069 gene polymorphism. The frequencies of homozygous MTHFR (C677T, A1298C) and heterozygous Factor XIII V34L were higher in the patient cohort compared to the controls.
Conclusion
In our study, we found that prothrombotic gene variants and APOA1 rs5069 polymorphism were statistically significantly related to coronary artery disease. So prothrombotic gene variants and APOA1 rs5069 polymorphism can be predictors of early myocardial infarctions, and those with early family histories can be screened among such mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Family Medicine, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir, Turkiye.
- Eskişehir Local Health Authority, Eskişehir, Turkiye.
- Department of Cardiology, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir, Turkiye.
- Department of Medical Genetics, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir, Turkiye.
ORCID-Profile: Hüseyin Balcioğlu, Elif Fatma Özkan Pehlivanoğlu, Uğur Bilge, Kadir Uğur Mert, Muhammet Dural, Ebru Erzurumluoğlu Gökalp, Oğuz Çilingir, Sevilhan Artan
Zitieren
APA
Balcioğlu, H., Özkan Pehlivanoğlu, E. F., Bilge, U., Mert, K. U., Dural, M., Erzurumluoğlu Gökalp, E., Çilingir, O., & Artan, S. (2024). Can prothrombotic gene variants and Apoa1 rs5069 polymorphism be the predictors of early myocardial infarctions?. Turkish Journal of Medical Sciences, 54(4), 682-687. https://doi.org/10.55730/1300-0144.5837
Vancouver
Balcioğlu H, Özkan Pehlivanoğlu EF, Bilge U, Mert KU, Dural M, Erzurumluoğlu Gökalp E, et al. Can prothrombotic gene variants and Apoa1 rs5069 polymorphism be the predictors of early myocardial infarctions?. Turkish Journal of Medical Sciences. 2024;54(4):682-687. doi:10.55730/1300-0144.5837
BibTeX
@article{Balciolu2024,
author = {Balcioğlu, Hüseyin and Özkan Pehlivanoğlu, Elif Fatma and Bilge, Uğur and Mert, Kadir Uğur and Dural, Muhammet and Erzurumluoğlu Gökalp, Ebru and Çilingir, Oğuz and Artan, Sevilhan},
title = {Can prothrombotic gene variants and Apoa1 rs5069 polymorphism be the predictors of early myocardial infarctions?},
journal = {Turkish Journal of Medical Sciences},
year = {2024},
volume = {54},
number = {4},
pages = {682--687},
doi = {10.55730/1300-0144.5837}
}
EUVIMED